Who Benefits From Astron And What Treatments Does Our Research Uncover?

Watch the complete presentation above for a detailed look who Astron could be beneficial for and what personalized treatment options we uncover for patients. The executive summary below covers key points from our video “Who Benefits From Astron And What Treatments Does Our Research Uncover?”, presented by Dr Padman, Chief Medical Officer at Astron Health.

---

Executive Summary

Astron’s personalized cancer approach benefits patients at all stages—not just those who’ve exhausted standard treatments. Our thesis is that almost any cancer patient could benefit from this approach, regardless of disease stage:

• At diagnosis: Guiding primary treatment decisions to enhance chances of optimal response
• Post-completion of primary treatment or at signs of early relapse: Targeting molecular vulnerabilities to mitigate recurrence risk
• During disease progression or with new symptoms: Reassessing molecular drivers to adapt treatment based on tumor evolution and resistance mechanisms
• During later stage disease: Finding ways to target multiple driver pathways to maintain disease equilibrium and reduce aggressive progression

Our comprehensive analysis of an individual’s unique cancer biology enables tailored treatment options to be uncovered that may include:

• Standard oncology drugs: used in novel ways based on tumor vulnerabilities
• Repurposed medications: with proven anti-cancer effects (metformin, aspirin)
• Natural evidence-backed supplements: targeting specific cancer pathways
• Customized lifestyle interventions: like the ketogenic diet for PIK3CA mutations

All personalized treatment options stem from peer-reviewed research and are selected for safety, tolerability, and proven mechanisms of action. We remain treatment-agnostic, prioritizing only what evidence suggests will be most effective for each patient’s unique cancer biology.

---

Astron advances precision oncology through data-driven research, providing specialized reports to patients under oncologist supervision when our insights may benefit treatment decisions. Patients should discuss with their clinician whether an Astron Report could support their care, or we can connect them with qualified oncologists familiar with our platform. Clinicians interested in collaboration opportunities can contact support@astron.health.